BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2022
View Archived Issues
Study shows disease-linked DNA variants are active at different stages of T-cell activation
Read More
Pendrin inhibitor ARBM-201 reduces lung injury in acute respiratory distress syndrome model
Read More
NLRP3 inflammasome inhibitor INF-176 for the treatment of Alzheimer's disease
Read More
MAb-loaded extracellular vesicles show potential as cancer therapeutics
Read More
Shanghai Yao Biotech discloses new TRK inhibitors
Read More
Sichuan Haisco Pharmaceutical patents ENPP2 inhibitors
Read More
Tyligand Bioscience divulges GTPase KRAS mutant inhibitors
Read More
Betta Pharmaceuticals identifies new IDH inhibitors
Read More
Broadenbio synthesizes new MAP4K1 inhibitors
Read More
Morc2 S87L mutation in mice mimics human Charcot-Marie-Tooth disease
Read More
TrxR inhibitor Au-24 shows promise in vivo and in vitro for treating hepatocellular carcinoma
Read More
Atux Iskay presents preclinical data on PP2A activator ATUX-792 in IPF
Read More